Holders over time
- DGX
- ELV
| Quarter | DGX | ELV |
|---|---|---|
| Q3 2020 | 18 holders, $1.0bn | 30 holders, $15.0bn |
| Q4 2020 | 21 holders, $1.1bn | 29 holders, $16.7bn |
| Q1 2021 | 19 holders, $1.2bn | 25 holders, $18.6bn |
| Q2 2021 | 14 holders, $975m | 30 holders, $19.4bn |
| Q3 2021 | 17 holders, $1.1bn | 26 holders, $18.5bn |
| Q4 2021 | 17 holders, $1.5bn | 29 holders, $23.3bn |
| Q1 2022 | 16 holders, $812m | 31 holders, $23.9bn |
| Q2 2022 | 16 holders, $813m | 32 holders, $23.3bn |
| Q3 2022 | 16 holders, $910m | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $1.1bn | 34 holders, $25.5bn |
| Q1 2023 | 17 holders, $989m | 39 holders, $22.5bn |
| Q2 2023 | 16 holders, $1.3bn | 38 holders, $20.6bn |
| Q3 2023 | 15 holders, $1.1bn | 34 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.2bn | 36 holders, $20.3bn |
| Q1 2024 | 10 holders, $777m | 35 holders, $21.3bn |
| Q2 2024 | 13 holders, $1.2bn | 33 holders, $22.1bn |
| Q3 2024 | 11 holders, $1.7bn | 30 holders, $20.2bn |
| Q4 2024 | 9 holders, $1.6bn | 32 holders, $15.9bn |
| Q1 2025 | 10 holders, $1.8bn | 28 holders, $17.1bn |
| Q2 2025 | 10 holders, $2.4bn | 27 holders, $14.8bn |
| Q3 2025 | 13 holders, $2.5bn | 27 holders, $12.7bn |
| Q4 2025 | 10 holders, $1.5bn | 25 holders, $17.0bn |
| Q1 2026 | 9 holders, $1.6bn | 26 holders, $13.6bn |
| Q2 2026 | 7 holders, $1.6bn | 28 holders, $17.7bn |
Quest Diagnostics Inc
- Holders
- 11
- Reported value
- $1.2bn
- Buyers
- 6
- Sellers
- 7
Breadth -1 among 93 comparable managers.
Elevance Health Inc Formerly
- Holders
- 36
- Reported value
- $20.3bn
- Buyers
- 10
- Sellers
- 27
Breadth -17 among 93 comparable managers.
Who holds both, Q4 2023
Both (10)
AllianceBernstein LP, Bridgewater Associates LP, ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Invesco Ltd, Marshall Wace LLP, Point72 Asset Management LP, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP
Only DGX (1)
Only ELV (26)
Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Citadel Advisors LLC, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Fidelity (FMR LLC), Glenview Capital Management LLC, Janus Henderson Group Ltd, Man Group PLC, Maverick Capital Ltd, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Steadfast Capital Management LP, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, and 1 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.